Skip to content

Comparison of cognitive impairment and seizure characteristics in manic patients receiving electroconvulsive therapy with or without concurrent treatment with sodium valproate.

Comparison of cognitive impairment and seizure characteristics in manic patients receiving electroconvulsive therapy with or without concurrent treatment with sodium valproate.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201101011743N4
Enrollment
40
Registered
2011-08-27
Start date
2010-09-24
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar disorder,Manic episode. Manic episode

Interventions

Intervention 1: During treatment with ECT that often lasts between 6 to 10 sessions, sodium valproate is continued in the control group. Intervention 2: During treatment with ECT that often lasts bet
Treatment - Drugs
During treatment with ECT that often lasts between 6 to 10 sessions, sodium valproate is continued in the control group.
During treatment with ECT that often lasts between 6 to 10 sessions, sodium valproate is discontinued in the case group.

Sponsors

Hamedan univercity of medical science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1. Manic episode based on DSM IV-TR 2. Age between 18 and 60 years 3. Elementary school education (at least) 4. ECT administer by attending physician Exclusion criteria: 1.Concurrent anticonvulsant therapy (except sodium valproate) 2. Severe cognitive impairment (MMSE = 19) befor the first session of ECT 3.Uncontrolled physical condition 4.Pregnant and nursing women 5. History of epilepsy 6. LFT > 3 fold the normal range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Seizure threshold. Timepoint: all session of ECT. Method of measurement: observation.;Duration of seizure. Timepoint: all session of ECT. Method of measurement: EEG.;Cognetive side effect. Timepoint: Befor the 1st ECTsession and after 3rd and 6th session. Method of measurement: MMSE.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Gholamreza Bigdeloo

Hamedan univercity of medical sciences

rbigdelou@yahoo.com+98 82 74184

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026